Furthermore, in GC, higher expression of METTL3 promotes cancer cell metastasis in vivo and is predictive of poor prognosis in GC patients, which is possibly through the m6A modified stabilization of the zinc finger MYM-type containing 1 (ZMYM1) mRNA. The gene discussed is METTL3; the disease is gastric cancer.